Vident Advisory’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$776K Sell
84,493
-14,472
-15% -$161K 0.01% 1118
2026
Q1
$1.07M Sell
98,965
-27,769
-22% -$238K 0.01% 849
2025
Q4
$774K Sell
126,734
-4,106
-3% -$24.5K 0.01% 927
2025
Q3
$678K Buy
130,840
+41,405
+46% +$238K 0.01% 1028
2025
Q2
$530K Buy
89,435
+74,194
+487% +$447K 0.01% 1013
2025
Q1
$125K Buy
15,241
+3,097
+26% +$26K ﹤0.01% 1487
2024
Q4
$100K Sell
12,144
-4,666
-28% -$37.4K ﹤0.01% 1402
2024
Q3
$129K Buy
16,810
+5,702
+51% +$52.5K ﹤0.01% 1364
2024
Q2
$115K Sell
11,108
-4,718
-30% -$51.7K ﹤0.01% 1346
2024
Q1
$189K Buy
+15,826
New +$176K ﹤0.01% 1226

Other funds holding PTEN

Vident Advisory's PTEN Position: Q2 2026 in Review

Vident Advisory reduced its Patterson-UTI (PTEN) stake by 15% in Q2 2026, selling an estimated $161K and leaving 84,493 shares worth $776K. The position accounts for 0.01% of the portfolio, ranked #1118.

Vident Advisory first reported a position in PTEN in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.07M in Q1 2026. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Vident Advisory held 84,493 shares of Patterson-UTI worth $776K as of Q2 2026.
  • Vident Advisory sold 14,472 Patterson-UTI shares in Q2 2026, an estimated $161K.
  • Patterson-UTI made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1118 holding.
  • Vident Advisory first reported a position in Patterson-UTI in Q1 2024 and has held it in 10 quarters since.
  • Vident Advisory's Patterson-UTI position peaked at $1.07M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.